Literature DB >> 10503811

Raynaud's phenomenon in older adults: diagnostic considerations and management.

S M Ling1, F M Wigley.   

Abstract

Raynaud's phenomenon (RP) is characterised by sensitivity to cold temperatures associated with either biphasic or uniphasic change in colour of the digits. Since few studies are available which include older adults, the prevalence of RP in the older adult population is estimated from surveys or studies of the general population. The causes of RP in older adults may differ significantly from those in young adults and, therefore, so would the evaluation of RP. Because of comorbitis that accompany advancing age, the management of RP in older adult patients must take into consideration toxicity and adverse reactions that may develop, especially in the frail individual. Although nonpharmacological therapy is preferable, slow-release calcium antagonists provide a relatively well tolerated and effective treatment for moderate to severe RP in older adult patients. Aggressive treatment including hospitalisation is appropriate for older adult patients during periods of critical digital ischaemia associated with RP.

Entities:  

Mesh:

Year:  1999        PMID: 10503811     DOI: 10.2165/00002512-199915030-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   4.271


  61 in total

1.  Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.

Authors:  C Cimminiello; M Milani; T Uberti; G Arpaia; S Perolini; G Bonfardeci
Journal:  Lancet       Date:  1991-01-12       Impact factor: 79.321

Review 2.  Physiological mechanisms of temperature biofeedback.

Authors:  R R Freedman
Journal:  Biofeedback Self Regul       Date:  1991-06

3.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

4.  "Primary Raynaud's" is not a disease or even a disorder; it's a trait.

Authors:  N M Hadler
Journal:  J Rheumatol       Date:  1998-12       Impact factor: 4.666

5.  The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon.

Authors:  P Pancera; S Sansone; S Secchi; G Covi; A Lechi
Journal:  J Intern Med       Date:  1997-11       Impact factor: 8.989

6.  Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.

Authors:  F M Wigley; R A Wise; J R Seibold; D A McCloskey; G Kujala; T A Medsger; V D Steen; J Varga; S Jimenez; M Mayes; P J Clements; S R Weiner; J Porter; M Ellman; C Wise; L D Kaufman; J Williams; W Dole
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

7.  Raynaud's phenomenon in rheumatoid arthritis.

Authors:  W Grassi; P Blasetti; P Core; C Cervini
Journal:  Br J Rheumatol       Date:  1994-02

Review 8.  Raynaud's phenomenon: a proposal for classification.

Authors:  E C LeRoy; T A Medsger
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

9.  Late onset systemic lupus erythematosus.

Authors:  S B Baker; J R Rovira; E W Campion; J A Mills
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

10.  Enalapril in Raynaud's phenomenon.

Authors:  S D Janini; D G Scott; J S Coppock; P A Bacon; M J Kendall
Journal:  J Clin Pharm Ther       Date:  1988-04       Impact factor: 2.512

View more
  5 in total

Review 1.  New lines in therapy of Raynaud's phenomenon.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

Review 2.  A Review of Raynaud's Disease.

Authors:  Katherine K Temprano
Journal:  Mo Med       Date:  2016 Mar-Apr

3.  Capillaroscopic pattern in paraneoplastic Raynaud's phenomenon.

Authors:  S Lambova; U Müller-Ladner
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

4.  Raynaud's syndrome: comparison of late and early onset forms using hand perfusion scintigraphy.

Authors:  Z Csiki; L Galuska; I Garai; N Szabó; J Varga; Cs András; M Zeher
Journal:  Rheumatol Int       Date:  2006-04-08       Impact factor: 2.631

Review 5.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.